Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Summer 2020 - Vaccines
Download Issue
Share
Up Front
Publisher's Corner
The Critical Need for Vaccines and Higher Vaccine-Compliance Rates
By Patrick M. Schmidt
Features
Exploring New Vaccine Delivery Methods
By
Jim Trageser
Counteracting the Anti-Vaccine Movement
By
Trudie Mitschang
Trends in U.S. Vaccine Compliance
By
Meredith Whitmore
Myths & Facts: Fibromyalgia
By
Ronale Tucker Rhodes, MS
An Update on Ebola
By
Amy Scanlin, MS
In the Shadow of COVID-19, Will Other Vaccine Development Programs Be Left Behind?
By
Show No Author
BioTrends Watch
Washington Report
Waiver Allows Medicare Patients to Receive Free Telehealth Services
FDA Campaign Designed to Help Consumers Use New Food Label
Finalized Rule Gives Patients More Control Over Their Health Data
Coronavirus Relief Funds to Pay for Care for Uninsured
Reimbursement FAQs
Data Integrity Vigilance: Telling Patient Pandemic Stories
Industry News
Rituxan Superior to Mycophenolate Mofetil in Sustaining Complete Remission in Pemphigus Vulgaris Patients
Competition Among Clinics Increased Influenza Vaccine Rates Among Patients, Study Showed
Measles Virus Destroys Immune System’s Memory of Past Infections
FDA Approves Biosimilar to Rheumatoid Arthritis Drug
Study of Kevzara from Severe to Critical COVID-19 Patients
Clinical Trial Will Assess IVIG for Treating COVID-19
Novartis Initiates Phase III Trial of Ilaris to Treat COVID-19 Patients with Pneumonia
Central Repository Created for SARS-CoV 2 Clinical Trials
Study Suggests MMR Vaccine May Be Linked with Fewer Deaths from COVID-19
BioFocus
Industry Insight
Are We Finally Closing In On a Universal Influenza Vaccine?
By Keith Berman, MPH, MBA
Patient Profile
Rabies: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Rabies: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Large-Dose Albumin Supplementation Does Not Reduce Mortality or Need for Critical Care Interventions: Retrospective Review
Bleed Protection with up to 14-Day Dosing of Long-Acting Recombinant Factor IX Product in Selected Children with Hemophilia B